Evidence map›Paper›PMID 34395709›Full record

ArticleOpen forum infectious diseases2021

Postacute Sequelae of SARS-CoV-2 Infection and Impact on Quality of Life 1-6 Months After Illness and Association With Initial Symptom Severity.

James B O'Keefe, H Caroline Minton, Mary Morrow, Colin Johnson, Miranda A Moore, Ghazala A D O'Keefe, Karima Benameur, Jason Higdon, Jessica K Fairley

Abstract read
In one paragraph

Article in Open forum infectious diseases, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 4 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 4 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Prevalence, risk factors and treatments for post-COVID-19 breathlessness: a systematic review and meta-analysis.European respiratory review : an official journal of the European Respiratory Society · 2022
    Pooled it
  5. Article
  6. Observational
  7. Article
  8. Article
  9. Systematic Review of the Prevalence of Long COVID.Open forum infectious diseases · 2023
    Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Brain Fog and Quality of Life at Work in Non-Hospitalized Patients after COVID-19.International journal of environmental research and public health · 2022
    Article
  16. Article
  17. Review
  18. Review
  19. Rehabilitation Strategies for Cognitive and Neuropsychiatric Manifestations of COVID-19.Current physical medicine and rehabilitation reports · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

James B O'KeefeDivision of General Internal Medicine, Department of Medicine, Emory University School of Medicine, Atlanta, Georgia, USA.ORCID https://orcid.org/0000-0002-7151-7184
H Caroline MintonRollins School of Public Health, Emory University, Atlanta, Georgia, USA.
Mary MorrowEmory Healthcare, Atlanta, Georgia, USA.
Colin JohnsonDepartment of General Surgery, Emory Bariatric Clinic, Emory Healthcare, Atlanta, Georgia, USA.
Miranda A MooreDepartment of Family and Preventive Medicine, Emory University School of Medicine, Atlanta, Georgia, USA.
Ghazala A D O'KeefeSection of Vitreoretinal Surgery and Diseases, Section of Uveitis and Vasculitis, Department of Ophthalmology, Emory University School of Medicine, Atlanta, Georgia, USA.
Karima BenameurDepartment of Neurology, Emory University School of Medicine, Atlanta, Georgia, USA.
Jason HigdonDivision of General Internal Medicine, Department of Medicine, Emory University School of Medicine, Atlanta, Georgia, USA.
Jessica K FairleyDivision of Infectious Diseases, Department of Medicine, Emory University School of Medicine, Atlanta, Georgia, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundIndividuals with coronavirus disease 2019 (COVID-19) may have persistent symptoms following their acute illness. The prevalence and predictors of these symptoms, termed postacute sequelae of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2; PASC), have not been fully described.

methodsParticipants discharged from an outpatient telemedicine program for COVID-19 were emailed a survey (1-6 months after discharge) about ongoing symptoms, acute illness severity, and quality of life. Standardized telemedicine notes from acute illness were used for covariates (comorbidities and provider-assessed symptom severity). Bivariate and multivariable analyses were performed to assess predictors of persistent symptoms.

resultsTwo hundred ninety patients completed the survey, of whom 115 (39.7%) reported persistent symptoms including fatigue (n = 59, 20.3%), dyspnea on exertion (n = 41, 14.1%), and mental fog (n = 39, 13.5%), among others. The proportion of persistent symptoms did not differ based on duration since illness (<90 days: n = 32, 37.2%; vs >90 days: n = 80, 40.4%;

conclusionsSymptoms following acute COVID-19 are common and may be predicted by factors during the acute phase of illness. Fatigue and neuropsychiatric symptoms figured prominently. Select symptoms seem to be particularly associated with perceptions of physical health following COVID-19 and warrant specific attention on future studies of PASC.

Indexed as

COVID-19PASCprolongedSARS-CoV-2symptoms

Identifiers

PMID34395709
PMCPMC8360237

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.